NICE says yes to another hepatitis C drug
A new drug which effectively treats more genotypes of hepatitis C has been recommended for use in the NHS.
NICE to recommend new drug to treat rare inherited bone disorder in children
NICE recommends ‘lifeline’ drug for babies and young children, in draft guidance.
Tailored care needed for people with more than one complex health condition
NICE calls for a tailored approach to care when treating someone who has two or more long-term health conditions.
NICE emphasises the importance of urgent referral in suspected melanoma
GPs should refer people with suspected malignant melanoma for an appointment within 2 weeks, says NICE in a new quality standard.
Latest news headlines
-
NICE issues first of its kind guidance on harmful sexual behaviour
Each school should have a named safeguarding lead and services should consider engaging with families before beginning an intervention, recommends NICE in new guidance.
20 September 2016
-
Change in practice could prevent 250 people a year having major surgery, says NICE
NICE prioritises four areas of head and neck cancer care for improvement.
19 September 2016
-
.jpg?v=636098700366783976)
Patients should be more involved in decisions about their care, says NICE
A new collaborative, made up of the UK’s leading health care organisations including NICE, has set out plans that will help get patients more involved in decisions about their care.
19 September 2016
-
NICE fellows and scholars programme opens for an eighth year
Applications to NICE’s (National Institute for Health and Care Excellence) prestigious Fellows and Scholar Programme are open.
12 September 2016
-
.jpg?v=636089733264575649)
More options to be made available to treat hepatitis C
Another ‘potential curative’ drug for people with chronic hepatitis C will be made available on the NHS.
-
NICE global care experts move to Imperial
The NICE team working with low and middle income countries to develop their health systems moves to Imperial College London
09 September 2016